Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening.

Summary: Tuberculosis (TB) bacteria are notoriously hard to kill because they are protected by a thick, armor-like cell wall. This makes treating the disease difficult, as many drugs simply cannot get inside. In this study, scientists used advanced computer simulations—a technique called "virtual screening"—to hunt for new chemicals capable of breaking this armor. They specifically targeted an enzyme called RmlD, which acts like a construction worker for the cell wall. The computer search successfully identified four new chemical compounds that stop this enzyme from working and prevent the bacteria from growing. This digital approach proved much more efficient than traditional laboratory trial-and-error methods, offering a promising new path for discovering effective TB treatments.